Mersana Therapeutics Inc.

0.53
-0.02 (-3.62%)
At close: Jan 22, 2025, 3:59 PM
0.53
-0.42%
After-hours Jan 22, 2025, 07:11 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -171.67M -204.21M -170.06M -88.05M -28.21M -64.26M -38.71M -13.70M -16.43M
Depreciation & Amortization 1.52M 927.00K 855.00K 1.01M 1.25M 1.26M 928.00K 655.00K 297.00K
Stock-Based Compensation 21.14M 21.52M 18.41M 7.17M 4.87M 3.88M 1.42M 668.00K 349.00K
Other Working Capital -42.68M 162.15M 9.60M 4.16M -41.38M -6.13M -10.05M 43.28M 3.72M
Other Non-Cash Items -1.10M -699.00K 723.00K 148.00K 103.00K 110.00K -159.00K 102.00K 349.00K
Deferred Income Tax n/a n/a n/a -86.00K -222.00K -386.00K -134.00K -102.00K -349.00K
Change in Working Capital -18.76M 133.10M 10.09M 5.11M -45.53M 4.18M -6.03M 43.97M 6.15M
Operating Cash Flow -168.88M -49.36M -139.99M -74.70M -67.74M -55.22M -42.68M 31.59M -9.64M
Capital Expenditures -2.17M -2.20M -648.00K -473.00K -605.00K -1.37M -1.14M -1.08M -619.00K
Acquisitions n/a 150.52M n/a n/a 26.69M n/a n/a n/a n/a
Purchase of Investments -155.92M -247.52M n/a n/a -53.69M n/a -145.70M n/a -164.00K
Sales Maturities Of Investments 277.97M 97.00M n/a 37.50M 27.00M 88.56M 47.22M n/a n/a
Other Investing Acitivies n/a -150.52M n/a 37.50M -26.69M 88.56M -98.48M n/a -164.00K
Investing Cash Flow 119.88M -152.72M -648.00K 37.03M -27.29M 87.19M -99.62M -1.08M -783.00K
Debt Repayment -262.00K -272.00K 18.34M -116.00K 4.88M n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a 146.00K n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 1.40M 2.40M 2.22M 3.50M 664.00K 1.06M 452.00K 58.26M 9.96M
Financial Cash Flow 94.67M 153.02M 63.65M 230.41M 97.70M 1.06M 68.60M 58.26M 9.96M
Net Cash Flow 45.68M -49.06M -76.99M 192.74M 2.67M 33.04M -73.71M 88.76M -459.00K
Free Cash Flow -171.05M -51.56M -140.64M -75.17M -68.35M -56.59M -43.82M 30.50M -10.26M